Muhammad Mohiuddin Transplant trailblazer
Over the past decade, however, advances in gene-editing technology have allowed researchers to remove specific pig proteins and sugars that trigger the human immune system, making the organs more compatible. Like many other scientists, Mohiuddin had applied to the US Food and Drug Administration (FD...
Saved in:
Published in: | Nature (London) Vol. 612; no. 7941; p. 623 |
---|---|
Main Author: | |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group
22-12-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Over the past decade, however, advances in gene-editing technology have allowed researchers to remove specific pig proteins and sugars that trigger the human immune system, making the organs more compatible. Like many other scientists, Mohiuddin had applied to the US Food and Drug Administration (FDA) for permission to test xenotransplantation in a clinical trial. [...]on New Year's Eve, the FDA approved the emergency procedure and the team scheduled the surgery for 7January. |
---|---|
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/d41586-022-04185-3 |